Company / EPS (Basic)
BioLife Solutions, Inc. EPS (Basic) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.09
FY2025
5-year range
-$3.29 / -$0.09
FY2021-FY2025
Trend
+79.5%
vs FY2024
Sector context
#94 of 160
Health Care
What the data says
At $-0.09, BioLife Solutions, Inc.'s eps (basic) ranks #94 of 160 in the Health Care sector. EPS (Basic) has increased for 3 consecutive years, from $-3.29 in FY2022 to $-0.09 in FY2025.
Based on SEC 10-K filings.
-0.09 in FY2025.
Improved from $-1.55 to $-0.09 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#94 of 160 in Health CareTop 59% of 160This company -$0.09 Sector average $1.67
▼
-105.4% below sector average
Key checks
Key Insights
- BioLife Solutions, Inc.'s eps (basic) has grown for 3 consecutive years.
- In FY2025, eps (basic) increased 79.5% year-over-year.
- Ranks #94 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.09 | +79.5% |
| FY2024 | -$0.44 | +71.6% |
| FY2023 | -$1.55 | +52.9% |
| FY2022 | -$3.29 | -1330.4% |
| FY2021 | -$0.23 | -428.6% |
| FY2020 | $0.07 | +177.8% |
| FY2019 | -$0.09 | +93.9% |
| FY2018 | -$1.48 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026